Loss of ABCA8B decreases myelination by reducing oligodendrocyte precursor cells in mice

Yiran Liu1, David Castano1, Francesco Girolamo2

  • 1Translational Laboratories in Genetic Medicine, Agency for Science, Technology and Research, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Cardiovascular Research Institute, National University Health System, Singapore, Singapore.

Journal of Lipid Research
|November 9, 2021
PubMed

Insights

The ATP-binding cassette transporter A8 (ABCA8) is crucial for cerebellar myelination. Its absence reduces oligodendrocyte precursor cells and impairs myelin sheath formation, impacting neurological function.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Myelin sheath disruption is implicated in neurological diseases like multiple sclerosis.
  • Sphingomyelin is a key myelin component, and ABCA8 influences its levels.
  • ABCA8 is highly expressed in the cerebellum, particularly in oligodendroglia.

Purpose of the Study:

  • To investigate the role of ABCA8 in cerebellar myelination.
  • To elucidate the mechanisms underlying ABCA8's function in myelination.

Main Methods:

  • Studied Abca8b knockout mice (Abca8b-/-).
  • Utilized immunofluorescence and electron microscopy.
  • Assessed oligodendrocyte precursor cell (OPC) numbers, myelin sheath characteristics, and neurological function.

Main Results:

  • Abca8b deficiency decreased cerebellar OPCs and mature oligodendrocytes.
  • ABCA8 interacts with CSPG4, crucial for OPCs and myelination.
  • Reduced CSPG4 plasma membrane localization and cerebellar expression in Abca8b-/- mice.
  • Abca8b deficiency led to thinner myelin, disordered ultrastructure, and impaired cerebellar conduction velocity.

Conclusions:

  • ABCA8 modulates cerebellar myelination, partly via CSPG4 regulation.
  • ABCA8 disruption may contribute to the pathology of myelin disorders.
  • Findings highlight ABCA8 as a potential therapeutic target for myelin-related diseases.

Related Concept Videos